Intratumoral treatment of one tumor lesion with LTX-315 induces complete tumor regression and long-term specific protective immune responses in a metastatic rodent tumor model

por Rekdal, Öystein, Nestvold, Janne, Wang, Meng Yu, Camilio, Ketil A, Sveinbjörnsson, Baldur, Kvalheim, Gunnar
Publicado 2014

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model

por Camilio, Ketil A., Wang, Meng-Yu, Mauseth, Brynjar, Waagene, Stein, Kvalheim, Gunnar, Rekdal, Øystein, Sveinbjørnsson, Baldur, Mælandsmo, Gunhild M.
Publicado 2019

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model

por Nestvold, Janne, Wang, Meng-Yu, Camilio, Ketil A., Zinöcker, Severin, Tjelle, Torunn Elisabeth, Lindberg, Alf, Haug, Bengt Erik, Kvalheim, Gunnar, Sveinbjørnsson, Baldur, Rekdal, Øystein
Publicado 2017